Diabetes tech often advances slowly because of hard constraints: safety, liability, FDA clearance, and reimbursement—so apps take years, pump designs stagnate, and algorithms lag behind what’s possible. In this episode, we unpack how those forces shape timelines and what’s being done to move faster without sacrificing safety. Joining me is Shannon Lantzy, a regulatory innovation expert who started at NASA, earned a PhD in decision science, and later worked with the FDA. She explains how review teams weigh risk, what safeguards drive approvals, and how universal testing standards and simulators could help companies ship meaningful updates sooner.

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

American Eagle Outfitters CEO. Dr. Michael Mina & Recapping Big Bank Earnings